Decentralized Clinical Trials (DCTs) colloquially known as hybrid trials were popularized during COVID-19. With the changing healthcare landscape, trial sponsors are looking for practices that are feasible and cost-effective. DCTs offer holistic solutions to mitigate the gaps in traditional clinical trial models by integrating emerging technologies and gadgets into the nuanced aspects of data capturing. With this article, let’s understand the significance of DCTs in the clinical trial landscape through trends, engaging articles, illustrative infographics, regulatory updates, and much more.
The July Edition of PharmaShots Magazine will revolve around the topic “Unlocking the Future: Insights into Regenerative Medicine” and the August Edition will focus on the Cosmeceutical Industry.
Get a chance to advertise with us! Send us your promotional pieces at connect@pharmashots.com
